Looking at the top 10 rankings of APAC pharma companies by pharma sales in 2021, two things are apparent – the impact of the ongoing COVID-19 pandemic and the steady rise into the top regional echelon of pharma companies from China. In some cases, the two were related.
Pandemic Drives China Surge In Asia 100 Sales
Notable new entrants moved into the Asia 100 this year, with growth catalyzed by COVID-19 vaccines.
